Harvard Bioscience
HBIO
HBIO
87 hedge funds and large institutions have $144M invested in Harvard Bioscience in 2021 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 27 increasing their positions, 32 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.05% less ownership
Funds ownership: 66.35% → 66.3% (-0.05%)
16% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 32
Holders
87
Holding in Top 10
1
Calls
$10K
Puts
$5K
Top Buyers
| 1 | +$1.48M | |
| 2 | +$1.38M | |
| 3 | +$1.15M | |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
+$1.13M |
| 5 |
AI
Acuitas Investments
Seattle,
Washington
|
+$1.09M |
Top Sellers
| 1 | -$1.69M | |
| 2 | -$1.38M | |
| 3 | -$818K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$729K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$419K |